Bio
Ranjana H. Advani, MD is the Saul Rosenberg Professor of Lymphoma and serves as the Physician Leader of the Lymphoma Clinical Care Program. She specializes in research and treatment of Hodgkin and non-Hodgkin lymphomas and has developed a broad collaborative investigative program, encompassing clinical trials and translational correlates. She is the Principle Investigator on numerous clinical trials. She currently serves on the National Comprehensive Cancer Network (NCCN) non Hodgkin and Hodgkin Lymphoma (vice chair) guidelines panel, Lymphoma Core Committee of the Eastern Cooperative Oncology Group (ECOG) and the National Cancer Institute Lymphoma Steering Committee.
Clinical Focus
- Cancer > Lymphoma
- Burkitt's Lymphoma
- Hodgkin's Disease
- Investigational Therapeutics
- Lymphoma
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
- Oncology (Cancer)
- Plasmacytoma
- Waldenstrom's Macroglobulinemia
- Medical Oncology
Academic Appointments
-
Professor - Med Center Line, Medicine - Oncology
-
Member, Stanford Cancer Institute
Administrative Appointments
-
Lymphoma DMG leader, Stanford Cancer Institute (2010 - Present)
Professional Education
-
Internship:Santa Clara Valley Medical Center Radiology Residency (1987) CA
-
Fellowship:Stanford University School of Medicine Registrar (1996) CA
-
Residency:Stanford University School of Medicine Registrar (1990) CA
-
Board Certification: Medical Oncology, American Board of Internal Medicine (1995)
-
Medical Education:Bombay University (1982) India